Paper36071908
Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning.
Germeraad RS and 2 others. Front Neurol, 2022. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning. Papers, record 36071908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36071908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1606341 | Generalized seizures secondary to high-dose busulfan therapy. | Ann Pharmacother | 1992 | https://conductscience.org/library/papers/1606341 | PubMed |
| 2 | 9489642 | Electroencephalogram abnormality and high-dose busulfan in conditioning regimens for stem cell transplantation. | Bone Marrow Transplant | 1998 | https://conductscience.org/library/papers/9489642 | PubMed |
| 3 | 30915718 | Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation. | Int J Hematol | 2019 | https://conductscience.org/library/papers/30915718 | PubMed |
| 4 | 16174888 | Phenytoin poisoning. | Neurocrit Care | 2005 | https://conductscience.org/library/papers/16174888 | PubMed |
| 5 | 19025431 | Optimal prevention of seizures induced by high-dose busulfan. | Pharmacotherapy | 2008 | https://conductscience.org/library/papers/19025431 | PubMed |
| 6 | 2265459 | The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2265459 | PubMed |
| 7 | 27746112 | Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. | Lancet Haematol | 2016 | https://conductscience.org/library/papers/27746112 | PubMed |
| 8 | 24768668 | Free phenytoin toxicity. | Am J Emerg Med | 2014 | https://conductscience.org/library/papers/24768668 | PubMed |
| 9 | 2753072 | Pharmacokinetic and metabolic studies of high-dose busulphan in adults. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2753072 | PubMed |
| 10 | 30871976 | Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30871976 | PubMed |
| 11 | 27722893 | Minimal incidence of neurotoxicity without prophylaxis during busulfan-based conditioning regimen in patients undergoing stem cell transplantation. | Int J Hematol | 2016 | https://conductscience.org/library/papers/27722893 | PubMed |
| 12 | 30083882 | Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients. | Cancer Chemother Pharmacol | 2018 | https://conductscience.org/library/papers/30083882 | PubMed |
| 13 | 4612168 | Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia. | J Natl Cancer Inst | 1974 | https://conductscience.org/library/papers/4612168 | PubMed |
| 14 | 27208016 | Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients. | J Oncol Pharm Pract | 2017 | https://conductscience.org/library/papers/27208016 | PubMed |
| 15 | 34335446 | Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation. | Front Neurol | 2021 | https://conductscience.org/library/papers/34335446 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41557115 | Association of busulfan area under the curve with the development of neurotoxicity in children and adolescents receiving busulfan-containing conditioning regimens for stem cell transplantation. | Int J Hematol | 2026 | https://conductscience.org/library/papers/41557115 | PubMed |
| 40514011 | Seizure Prophylaxis and its Impact on Busulfan Pharmacokinetics and Dosing in a Novel Timed Sequential Protocol: MD Anderson Experience. | Transplant Cell Ther | 2025 | https://conductscience.org/library/papers/40514011 | PubMed |
| 40319193 | Mechanisms underlying seizures and hypothermia during busulphan administration. | Bone Marrow Transplant | 2025 | https://conductscience.org/library/papers/40319193 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36071908
GET https://conductscience.org/api/papers/v1/36071908/authors